Related references
Note: Only part of the references are listed.Resistance to proteasome inhibitors and other targeted therapies in myeloma
Craig T. Wallington-Beddoe et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression
Rui-lian Xu et al.
EXPERIMENTAL CELL RESEARCH (2018)
Soluble and cell-cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma
Mariah L. Farrell et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
PARP inhibitors: Clinical utility and possibilities of overcoming resistance
Benjamin G. Bitler et al.
GYNECOLOGIC ONCOLOGY (2017)
The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis
Yingchun Liang et al.
CELL DEATH & DISEASE (2017)
MicroRNA regulation of progesterone receptor in breast cancer
Avital Gilam et al.
ONCOTARGET (2017)
TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-kβ inhibition
Prahlad V. Raninga et al.
CELL CYCLE (2016)
MicroRNAs and Cancer Resistance: A New Molecular Plot
F. Fanini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date
Daniel Pievsky et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2016)
An overview of microRNAs
Scott M. Hammond
ADVANCED DRUG DELIVERY REVIEWS (2015)
Understanding drugs in breast cancer through drug sensitivity screening
Katharina Uhr et al.
SPRINGERPLUS (2015)
Let-7 miRNAs Modulate the Activation of NF-κB by Targeting TNFAIP3 and Are Involved in the Pathogenesis of Lupus Nephritis
Jun Liu et al.
PLOS ONE (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel - a review
Vincent A. de Weger et al.
ANTI-CANCER DRUGS (2014)
Identification and consequences of miRNA-target interactions - beyond repression of gene expression
Jean Hausser et al.
NATURE REVIEWS GENETICS (2014)
MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis
W. Wu et al.
BRITISH JOURNAL OF CANCER (2013)
Identification of miRNA modulators to PARP inhibitor response
Sari Neijenhuis et al.
DNA REPAIR (2013)
Epigenetics and ncRNAs in Brain Function and Disease: Mechanisms and Prospects for Therapy
Miguel A. Varela et al.
NEUROTHERAPEUTICS (2013)
Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition
L. Guo et al.
ONCOGENE (2013)
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs
Muhammad Riaz et al.
BREAST CANCER RESEARCH (2013)
Lapatinib-induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors
Yun-Ju Chen et al.
BREAST CANCER RESEARCH (2013)
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Marilena V. Iorio et al.
EMBO MOLECULAR MEDICINE (2012)
Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cells
Anne Saumet et al.
MOLECULAR BIOSYSTEMS (2012)
Targeting MET in cancer: rationale and progress
Ermanno Gherardi et al.
NATURE REVIEWS CANCER (2012)
PARP inhibitors - current status and the walk towards early breast cancer
Jennifer Glendenning et al.
BREAST (2011)
Primate-Specific microRNA-637 Inhibits Tumorigenesis in Hepatocellular Carcinoma by Disrupting Signal Transducer and Activator of Transcription 3 Signaling
Jin-fang Zhang et al.
HEPATOLOGY (2011)
miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors
Patryk Moskwa et al.
MOLECULAR CELL (2011)
MicroRNAs in body fluids-the mix of hormones and biomarkers
Maria Angelica Cortez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Gene silencing by microRNAs: contributions of translational repression and mRNA decay
Eric Huntzinger et al.
NATURE REVIEWS GENETICS (2011)
MicroRNAs in the Pathogenesis of Cancer
Francesca Lovat et al.
SEMINARS IN ONCOLOGY (2011)
An overview of the c-MET signaling pathway
Shawna Leslie Organ et al.
Therapeutic Advances in Medical Oncology (2011)
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
Antoinette Hollestelle et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Histone Deacetylase Inhibitors Activate NF-κB in Human Leukemia Cells through an ATM/NEMO-related Pathway
Roberto R. Rosato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Estradiol Suppresses NF-κB Activation through Coordinated Regulation of let-7a and miR-125b in Primary Human Macrophages
Amy J. Murphy et al.
JOURNAL OF IMMUNOLOGY (2010)
ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
Neru Munshi et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Mammalian microRNAs predominantly act to decrease target mRNA levels
Huili Guo et al.
NATURE (2010)
The widespread regulation of microRNA biogenesis, function and decay
Jacek Krol et al.
NATURE REVIEWS GENETICS (2010)
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
Fiona M. Blows et al.
PLOS MEDICINE (2010)
MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response
Joris Pothof et al.
EMBO JOURNAL (2009)
A 2-gene classifier for predicting response to the famesyltransferase inhibitor tipifarnib in acute myeloid leukemia
Mitch Raponi et al.
BLOOD (2008)
The role of microRNAs in cancer: No small matter
Erik A. C. Wiemer
EUROPEAN JOURNAL OF CANCER (2007)
Paclitaxel and docetaxel resistance: Molecular mechanisms and development of new generation taxanes
Elena Galletti et al.
CHEMMEDCHEM (2007)
Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia
Mitch Raponi et al.
CLINICAL CANCER RESEARCH (2007)
Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach
S. Tozlu et al.
ENDOCRINE-RELATED CANCER (2006)
miRBase: microRNA sequences, targets and gene nomenclature
Sam Griffiths-Jones et al.
NUCLEIC ACIDS RESEARCH (2006)
How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study
AM Sieuwerts et al.
CLINICAL CANCER RESEARCH (2005)
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1
JS Carroll et al.
CELL (2005)
Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients
JC Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A global test for groups of genes: testing association with a clinical outcome
JJ Goeman et al.
BIOINFORMATICS (2004)
Statistical significance for genomewide studies
JD Storey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular cytogenetic analysis of breast cancer cell lines
JM Davidson et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
